Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Bone
Reexamination Certificate
1996-11-01
2003-08-05
Willse, David H. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Bone
C623S023510, C623S023440, C623S023580, C606S075000
Reexamination Certificate
active
06602293
ABSTRACT:
BACKGROUND OF THE INVENTION
The invention relates to orthopedic (bone) implants which are used to replace a missing or diseased portion of bone. Several conditions can lead to the loss of bone including trauma, arthritic diseases, tumors, musculoskeletal defects, and the replacement of a failed implant.
An intramedullary implant is generally used in long bones (i.e., the femur and humerus), and is inserted into the medullary canal, which runs through, the diaphysis (shaft) of the bone and is filled with bone marrow. A long bone implant is one of two different types of intramedullary implants, the other being categorized as joint replacements. The joint replacement implants (i.e., a hip or knee implant) have a much more complicated geometry, than the rod-like, long bone replacement. Both types of implants have shown similar modes of failure in clinical studies.
The intramedullary implants being used today are generally fabricated from metal, using an alloy of either titanium (Ti) or cobalt chrome (Co-Cr). The joint replacement implants are primarily made with a Co-Cr alloy containing molybdenum (Mo), which is added to improve the wear resistance properties of the material, an important consideration when the implant is used to replace articulating surfaces.
Long bone replacement implants are most commonly fabricated from Ti, either in its commercially pure state or as an alloy with aluminum and vanadium. These materials have been experimentally and clinically proven to be biocompatible. It is not completely understood biochemically, but the bone tissue grows and attaches to the surface of Ti more readily than to other materials. This property allows Ti to aid in the fixation of the implant in bone, an extremely important part of the operation directly affecting the duration of success.
It is important for implant success that the implant remain stationary so the bone tissue can begin to grow around it. Initial stabilization is achieved through the use of bone cement applied during surgery, which acts as a filler between the bone and the implant. The interfacial space is filled with cement to stabilize the implant and inhibit motion. The bone cement material is a thermoset particulate composite polymer called polymethylmethacrylate (PMMA).
Long term stabilization of the implant in bone is achieved by having a porous coating on the surface of the implant. The porous coating is either added or molded onto the surface of the implant. Ti or hydroxyapatite (HA) are two materials with good biocompatibility and/or biostimulating factors commonly used to create this porous coating. Ti is sintered onto the metal (e.g., Ti) implant in either a mesh of crimped wire or a random array of particulates. The HA is applied to the surface of the implant using plasma spraying techniques.
The surface coating must have large enough pores to allow the bone cells to travel through and create a strong interlocking fixation by reconnecting with adjacent bone tissue throughout the mesh. This method of fixation relies on the connection of the bone tissue to hold the implant in place. If the bone tissue does not grow fast or is not strong enough, the implant is not completely stabilized and micromotion can occur.
Problems with current implant designs stem from the difference in mechanical properties between the materials used in the implant system and the bone itself. The Ti alloy has an elastic modulus equal to 110.3 GPa (16.0×10
6
psi), and the Co—Cr alloy has an elastic modulus equal to 210.3 GPa (30.5×10
6
psi). In comparison to the modulus of cortical bone, equal to about 13.8 GPa (2.0×10
6
psi), these metallic implants are a minimum of eight times stiffer. This large gradient causes stress shielding across the implant-bone interface, where the implant supports and absorbs most of the load and leaves the bone virtually inactive and unstressed.
As stated in Wolff's law, bone needs to be cyclically stressed to survive and remain strong enough to support the body. The shielded, unstressed bone around a metal implant begins to resorb and cavities form between the implant and the bone. The cavities weaken the fixation and allow micromotion of the implant in the bone, eventually producing local wear debris. Microscopic foreign body wear debris in the surrounding tissue will trigger the body's defense mechanism and cause infectious reactions. Loosening of the implant is irreversible without intervention and ultimately leads to a revision operation. A patient can only undergo two or three additional procedures before the bone becomes too weak and osteoporotic to support another replacement and is considered non-functional.
SUMMARY OF THE INVENTION
The isoelastic bone-implant system of the invention minimizes, if not eliminates, the stress shielding effect created by a metal implant, thus, leading to a longer implant lifetime in the body. In one embodiment, a thermoplastic polymer with an elastic modulus approximating the modulus of bone is used for the implant.
Since bone is a natural composite material composed of a matrix with organic and inorganic substances, composites are also an excellent choice of materials to use for implants, specifically for those situations where material properties have a large impact on the implant's success, such as replacement of a hip. Hence, a second embodiment comprises a composite comprising a thermoplastic polymer and a reinforcing material, the composite having an elastic modulus approximating the elastic modulus of bone. The composite preferably comprises polyetheretherketone (PEEK), a high temperature thermoplastic, containing preferably 10% by volume of chopped E-glass fibers which results in a material having approximately the same stiffness as bone and, therefore, in a significant improvement with respect to the stress-shielding problem.
The final step is the application or formation of a porous coating on the surface of the implant to create the porous environment for bone ingrowth. The coating can comprise hydroxy-apatite applied to the surface, a roughness formed on the surface, or a biocompatible material such as titanium embedded in the surface.
A two piece embodiment of an intramedullary implant is joined and locked together, after the opposite ends of each piece are inserted in the medullary canal, using an interlocking mechanism comprising a fluted protrusion on one piece and a corresponding fluted cavity in the other piece with the fluted portions being complementarily tapered.
REFERENCES:
patent: 4038703 (1977-08-01), Bokros
patent: 4190044 (1980-02-01), Wood
patent: 4262665 (1981-04-01), Roalstad et al.
patent: 4355429 (1982-10-01), Mittelmeier et al.
patent: 4375810 (1983-03-01), Belykh et al.
patent: 4479271 (1984-10-01), Bolesky et al.
patent: 4516569 (1985-05-01), Evans et al.
patent: 4578384 (1986-03-01), Hollinger
patent: 4634445 (1987-01-01), Helal
patent: 4688561 (1987-08-01), Reese
patent: 4750905 (1988-06-01), Koeneman et al.
patent: 4781181 (1988-11-01), Tanguy
patent: 4790302 (1988-12-01), Colwill et al.
patent: 4808186 (1989-02-01), Smith
patent: 4813960 (1989-03-01), Muller
patent: 4827919 (1989-05-01), Barbarito et al.
patent: 4834747 (1989-05-01), Gogolewski
patent: 4834756 (1989-05-01), Kenna
patent: 4863475 (1989-09-01), Andersen et al.
patent: 4877019 (1989-10-01), Vives
patent: 4898186 (1990-02-01), Ikada et al.
patent: 4946459 (1990-08-01), Bradhshaw et al.
patent: 4955911 (1990-09-01), Frey et al.
patent: 4978355 (1990-12-01), Frey et al.
patent: 5009664 (1991-04-01), Sievers
patent: 5032129 (1991-07-01), Kurze et al.
patent: 5053035 (1991-10-01), McLaren
patent: 5098433 (1992-03-01), Freedland
patent: 5108398 (1992-04-01), McQueen et al.
patent: 5122141 (1992-06-01), Simpson et al.
patent: 5171284 (1992-12-01), Branemark
patent: 5181930 (1993-01-01), Dumbleton et al.
patent: 5236457 (1993-08-01), Devanathan
patent: 5244623 (1993-09-01), King
patent: 5248313 (1993-09-01), Greene et al.
patent: 5250049 (1993-10-01), Michael
patent: 5281226 (1994-01-01), Davydov et al.
patent: 5334184 (1994-08-01),
Biermann Paul J.
Corvelli Amy A.
Roberts Jack C.
Cooch Francis A.
The Johns Hopkins University
Willse David H.
LandOfFree
Polymeric composite orthopedic implant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymeric composite orthopedic implant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymeric composite orthopedic implant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3107339